timothy sykes logo

Stock News

Oscar Health Q3 Loss Deepens Beyond Expectations

Matt MonacoAvatar
Written by Matt Monaco Reviewed by Jack Kellogg Fact-checked by Tim Sykes
Updated 11/10/2025, 11:33 am ET 11/10/2025, 11:33 am ET | 4 min 4 min read
Oscar Health Q3 Loss Deepens Beyond Expectations Thumbnail

Oscar Health Inc. stocks have been trading down by -15.43 percent amid declining interest and enrollment concerns.

Candlestick Chart

Live Update At 11:32:51 EST: On Monday, November 10, 2025 Oscar Health Inc. stock [NYSE: OSCR] is trending down by -15.43%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

Oscar Health announced results for the third quarter, noting a net loss of $0.53 per share, surpassing analysts’ expectations for a $0.48 loss per FactSet. Such figures are often quite telling of the company’s fiscal health. Examining this period, revenues stood at approximately $2.99B. However, total expenses surpassed revenues, amounting to over $3.11B.

The current trends reflected in the stock charts are intriguing. Each line tells its own story. For instance, from Nov 5, 2025, the opening price was around $17.17, closing at $17.03, showing minor shifts on that day. This echoes the uneasy atmosphere surrounding the stock after recent news.

Market Reactions: Investor Sentiments and Predictions

A closer look at Oscar Health’s recent activities paints a vivid picture. The rise in unpredictability of its earnings might cast shadows over investor confidence. For a company operating in a sector as volatile as health insurance, realizing losses exceeds analyst forecasts, inevitably sowing seeds of doubt among traders and long-term investors.

On top of that, their financial statements reveal profit margins that are deep in the negative. Specifically, the company showed a gross margin with a glaring emptiness, quickly followed by pre-tax and total profit margins standing at a negative 5.6% and 2.16%, respectively. It’s an intricate dance, balancing revenues and expenses, and right now, OSCR seems off-step.

Oscar Health’s high leverage ratio of 5.6 indicates a significant degree of financial risk. Factor in return ratios, with a dismal return on equity of roughly negative 29.69%, and it’s like watching a thunderstorm brew on the financial horizon. It’s an area where careful monitoring is essential. For stakeholders, the company’s strategy needs to shift with urgency, ushering in transformative projects to steer back towards profitability. The financial landscape suggests a bumpy path ahead—it’s not just about weathering the storm but strategically maneuvering through it.

More Breaking News

Conclusion: Future Paths and Insights

These earnings test the resilience of Oscar Health and its trajectory meticulously. The spotlight now shifts to their strategic responses. Can they turn the tide? Historically, stocks under similar fiscal pressures have implemented cost rationalization or ventured into new markets. For Oscar Health, aligning their core strategies with operational efficiency can stem financial bleeding. Diversification into emerging markets or leveraging advanced AI models could strengthen standing. Stockholders watch closely. Their movement, swayed by numbers, balance, and hope, depend on Oscar Health’s ability to embrace innovation amidst adversity.

As millionaire penny stock trader and teacher Tim Sykes says, “You must adapt to the market; the market will not adapt to you.” This trading insight is vital as Oscar Health navigates through changing financial environments, emphasizing the need to adjust swiftly and strategically. It is clear: the sun won’t set on opportunities for Oscar without a fight. Amid potential pitfalls, there lies room for growth—pursue it steadfastly. As fiscal chapters unfold, what unfolds next depends on how swiftly Oscar Health embraces change, steering towards a more lucrative horizon.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply
Author card Timothy Sykes picture

Matt Monaco

Mentor and Trainer at StocksToTrade.com, Lead Mentor at Small Cap Rockets and To The Moon Report
He is a diligent trader and teacher in his To The Moon Report blogs and Small Cap Rockets strategy webinars. He shows up every day, and expects his students to as well. Matt is fond of trading sketchy, volatile OTC stocks with profit potential. His favorite patterns are panic dip buys and breakouts.
Read More

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”